Mackenzie Financial
NPTN

Mackenzie Financial’s NEOPHOTONICS CORP NPTN Stock Holding History

Mackenzie Financial’s Portfolio NPTN Stock Details NPTN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-10,860
Closed -$79K – 1162
2020
Q1 		$79K Buy
+10,860
New +$80.5K ﹤0.01% 1031

Other funds holding NPTN

Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mackenzie Financial's NPTN Position: Q2 2020 in Review

Mackenzie Financial sold out of NEOPHOTONICS CORP (NPTN) in Q2 2020, closing a stake of 10,860 shares — an estimated $79K sold.

Mackenzie Financial first reported a position in NPTN in Q1 2020 and held it in 1 quarter. The position peaked at $79K in Q1 2020. 163 funds tracked by Wall St. Rank hold NPTN as of Q2 2020.

  • Mackenzie Financial reported no remaining NEOPHOTONICS CORP position as of Q2 2020 after selling out during the quarter.
  • Mackenzie Financial sold 10,860 NEOPHOTONICS CORP shares in Q2 2020, an estimated $79K.
  • Mackenzie Financial first reported a position in NEOPHOTONICS CORP in Q1 2020 and held it in 1 quarter.
  • Mackenzie Financial's NEOPHOTONICS CORP position peaked at $79K in Q1 2020.
  • 163 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q2 2020.

Based on Mackenzie Financial's 13F filing for Q2 2020, filed 13 Aug 2020.